FORMOLINE

FORMOLINE L112 tablets

Important notes (mandatory information)

formoline L112, tablets.

Indications

for supporting the treatment of overweight, weight control and reduction of cholesterol absorption from food.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

formoline L112, tablets

Indications

Lipid binder for supporting the treatment of overweight, weight control and reduction of cholesterol absorption from food.

Mode of action

formoline L112 reduces the calorie intake from dietary fats. The main ingredient in formoline L112 is the fibre polyglucosamine (L112). It is of natural origin and, due to its very high fat-binding capacity, can bind large amounts of dietary fats in the digestive tract. The absorption of dietary fats from the intestine is thus reduced. The main ingredient of formoline L112 is indigestible and is excreted naturally with the fats bound to it. In addition, the indigestible and swollen fibres of formoline L112 have a slightly satiating effect. formoline L112 primarily affects overweight caused by a high-fat diet such as fatty meat, sausage, butter, cheese, crisps, nuts, cakes or ice cream. Other food components such as sugar, carbohydrates, protein or alcohol are not bound by formoline L112; these calories should be reduced as they are fully available to the body. Taking formoline L112 is not recommended with meals rich in vitamins (salad/vegetables) with high-quality oils or omega-3 fatty acids (salmon, etc.), as the fat-soluble vitamins and essential fatty acids can be partially bound. Taking formoline L112 can temporarily change the consistency of the stool. In very rare cases, digestive problems (constipation, flatulence, bloating) have been observed with insufficient fluid intake. Short-term weight gain is possible in case of constipation. Allergic reactions to one of the ingredients or in case of an existing allergy to house dust mites are possible in very rare cases (symptoms may include: diarrhoea, vomiting, nausea, rash, swelling, itching, sweating, tingling, chills, dizziness, headache). Overall, however, formoline L112 can be described as very well tolerated.

If any of the described interactions or side effects occur, it is recommended to discontinue formoline L112 and, if necessary, consult a doctor or pharmacist.

Recommended intake:

• For weight loss: 2 x daily 2 tablets of formoline L112 with the two meals with the highest fat content, ideally towards the end of the meal.
• For weight control: 2 x daily 1 tablet of formoline L112 with the two meals with the highest fat content, ideally towards the end of the meal.

formoline L112 should be taken whole with as little calorie-containing liquid as possible (at least 250 ml) to achieve an optimal effect and to ensure the best possible transport of the tablets to the stomach. Since formoline L112 is a high-fibre preparation, a sufficient fluid intake of at least 2 litres per day is recommended. In order to stabilise the weight in the long term after losing weight, formoline L112 can be used in a dosage of 1 tablet with each of the two main meals. To support weight loss and weight control with formoline L112, a balanced, low-fat and low-calorie diet (60 - 80 g fat per day) and physical exercise are recommended. Before making any long-term changes to your diet, it is advisable to seek medical advice. To ensure the supply of fat-soluble vitamins A, D, E and K, as well as essential fatty acids, we recommend taking formoline L112 with only 2 out of 3 main meals. In addition, at least one meal per day should be consumed with high-quality oils and fats that supply the body with fat-soluble vitamins and essential fatty acids. A multivitamin preparation can also supplement the vitamin requirement.

Duration of use

formoline L112 can be taken long-term.

Contraindications

formoline L112 should only be taken after consulting a doctor in the case of:

• long-term medication
• serious gastrointestinal diseases (ulcerative colitis, Crohn's disease, diverticulitis, short bowel syndrome, stomach ulcer, pronounced irritable bowel, drug-treated reflux, etc.) and after operations in the gastrointestinal tract
• chronic digestive problems (constipation, sluggish bowels, etc.)
• children and adolescents who are still growing
• the elderly (over 80 years of age)
• long-term use of medications that reduce bowel activity.

formoline L112 should not be taken by the following persons:

• infants and toddlers up to the age of 3 years
• persons who are underweight (BMI < 18.5)
• persons with a known allergy to crustacean products or any of the ingredients.

Use during pregnancy and breastfeeding

During pregnancy or breastfeeding, overweight should not be treated or should only be treated under medical supervision. The best possible nutrient supply is necessary for the embryonic development and for the optimal supply of the infant with breast milk.

Other information

formoline L112 is a medical device certified throughout the EU by an officially authorised body and registered under registration number "DE/CA64/Certmedica/001". The quality and performance of the active ingredient are strictly tested before manufacture. It is recommended to store the formoline L112 tablets in the blister until they are taken. Store formoline L112 at room temperature. Store in a cool and dry place at elevated room temperature, for example in a refrigerator with automatic defrosting.

Warnings

Observe the expiry date.

Composition

Active ingredient: Specification L112 of ß-1,4-polymer from D-glucosamine and N-acetyl-DGlucosamine, from crustacean shells. Excipients: cellulose (vegetable), vitamin C, tartaric acid, tabletting aids.

Additional information

Contains no preservatives or colourings. Gelatine-, lactose-, gluten-, milk protein- and cholesterol-free, also recommended for diabetics (no BE calculation). No flavour enhancers. formoline L112 is a product of natural origin. Colour and taste variations are therefore possible and have no influence on the effectiveness.

Pack sizes

48, 80 and 160 tablets.

Manufacturer

Certmedica International GmbH
Magnolienweg 17
63741 Aschaffenburg
Germany
kontakt@formoline.de

Information status: March 2015.

Source: Information from the package leaflet
Status: 10/2017
Indications: for supporting the treatment of overweight, weight control and reduction of cholesterol absorption from food.